Shares of BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) traded up 0.6% during trading on Wednesday . The company traded as high as $1.73 and last traded at $1.71. 7,301 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 13,166 shares. The stock had previously closed at $1.70.
BeyondSpring Stock Up 2.9 %
The stock has a 50-day simple moving average of $1.69 and a 200 day simple moving average of $1.91.
BeyondSpring Company Profile
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Further Reading
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
